Impact of Cardiac Rehabilitation Programs on Left Ventricular Remodeling After Acute Myocardial Infarction - the REHAB Trial
Launched by CARDIO MED MEDICAL CENTER · Nov 11, 2019
Trial Information
Current as of May 29, 2025
Completed
Keywords
ClinConnect Summary
While the role of early mobilization in the immediate postinfarction period has been well demonstrated, little is known in present about the link between early mobilization and reduction of systemic inflammation. At the same time, the impact of early mobilization on regression of left ventricular remodeling has not been elucidated so far.
The study will be a single-center, observational, non-randomized study, which will be carried out in the Center of Advanced Research in Multimodal Cardiac Imaging Cardiomed, including 100 patients with AMI, presenting with either ST-segment elevation acut...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with AMI in the last 12 hours;
- • Successful revascularization of the culprit artery within the first 12 hours after the onset of symptoms in STEMI or within first 48 hours in NSTEMI (according to the risk class);
- • Signed written informed consent.
- Exclusion Criteria:
- • Patient refusal;
- • Any condition that would contraindicate CMR examination;
- • Women during pregnancy or lactation period;
- • Women able to procreate without any contraceptive usage;
- • Chronic kidney disease (glomerular filtration rate \<60ml/min/1.73m2) or acute renal injury that requires hemodialysis;
- • Any type of neoplasia documented in the last 3 years before randomization;
- • Expectation of life \< 1 year.
About Cardio Med Medical Center
Cardio Med Medical Center is a leading healthcare institution dedicated to advancing cardiovascular research and patient care. With a focus on innovative clinical trials, the center is committed to exploring cutting-edge therapies and interventions that improve heart health and overall patient outcomes. Equipped with state-of-the-art facilities and a team of experienced specialists, Cardio Med fosters a collaborative environment where scientific inquiry and clinical excellence converge. The center prioritizes patient safety and ethical standards, ensuring that all research initiatives contribute to the broader understanding of cardiovascular diseases and enhance treatment options for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Targu Mures, , Romania
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials